DexCom, Inc. (NASDAQ:DXCM) Q1 2020 Earnings Conference Call April 28, 2020 4:30 PM ET Company Participants Sean Christensen – Senior Investor Relations Manager Kevin Sayer – Chairman, President and Chief Executive Officer Quentin Blackford – Chief Operating Officer and Chief Financial Officer Steve Pacelli – Executive Vice President of Strategy and Corporate Development Conference Call Participants Robbie Marcus – JPMorgan Danielle Antalffy – Leerink Jeff Johnson – Baird Matthew O'Brien – Piper Jaffray Trav ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51222 DEXCOM, INC. (Exact name of Registrant as specified in its charter) Delaware 33-0857544 (State or Other Jurisdiction o ...

DexCom, Inc. (NASDAQ:DXCM) Q4 2019 Earnings Conference Call February 13, 2020 4:30 PM ET Company Participants Sean Christensen - Senior IR Manager Kevin Sayer - Executive Chairman, CEO & President Quentin Blackford - EVP, CFO & COO Steven Pacelli - EVP, Strategy & Corporate Development Conference Call Participants Jeffrey Johnson - Robert W. Baird & Co. Jayson Bedford - Raymond James & Associates Travis Steed - Bank of America Merrill Lynch Robert Marcus - JPMorgan Chase & Co. Malgorzata Kaczor - William Bl ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51222 DEXCOM, INC. (Exact name of Registrant as specified in its charter) Delaware 33-0857544 (State or Other Jurisdiction of Incorporation or Organi ...

DexCom, Inc. (NASDAQ:DXCM) Q3 2019 Results Earnings Conference Call November 6, 2019 4:30 PM ET Company Participants Sean Christensen - Senior Investor Relations Manager Kevin Sayer - Chairman, President and Chief Executive Officer Quentin Blackford - Executive Vice President and Chief Financial Officer Steven Pacelli - Executive Vice President of Strategy and Corporate Development Conference Call Participants Danielle Antalffy - SVB Leerink Margaret Kaczor - William Blair Jeffrey Johnson - Baird Ryan Blick ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51222 DEXCOM, INC. (Exact name of Registrant as specified in its charter) Delaware 33-0857544 (State or Other Jurisdicti ...